Madrid

• The ACTION Study: ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy Recruiting
  2022-502051-56-00 5 2023-04-28 H3 K27M-mutant diffuse glioma
• A Study of Aztreonam-Avibactam (ATM-AVI) Compared to Best Available Therapy in Pediatric Participants with Serious Gram-Negative Bacterial C … Recruiting
  2022-501575-12-00 4 2023-04-24 Hospital-Acquired Pneumonia
• Master protocol of novel combinations in participants with locally advanced unresectable or metastatic gastric or gastroesophageal junction … Recruiting
  2024-510977-27-00 4 2023-04-14 Locally Advanced Unresectable or Metastatic Gastric or Gastroesophagea
• A first-in-human clinical study of PBP1510 in patients with pancreatic cancer. Recruiting
  2024-514379-16-00 7 2023-04-01 Advanced and/or metastatic pancreatic adenocarcinoma
• Study to evaluate the ability of a sublingual vaccine to induce the expression of trained immunity in peripheral blood cells Recruiting
  2024-516720-34-00 9 2023-03-31 Healthy adult males and non-pregnant females
• Phase 1 Study of AMG 509 in Subjects With Metastatic Castration-Resistant Prostate Cancer Recruiting
  2023-504361-23-00 1 2023-03-30 Metastatic Castration-Resistant Prostate Cancer (mCRPC)
• A Phase 2/3 Randomized, Placebo-Controlled, Double-blind, Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vericigua … Recruiting
  2022-501238-52-00 10 2023-03-23 Heart failure due to systemic left ventricular systolic dysfunction
• A study investigating the use of EP0031 in patients with cancers having an abnormal RET gene. Recruiting
  2022-501636-42-00 9 2023-03-21 Advanced RET-altered malignancies
• A Phase 2 Master Protocol to assess the efficacy and safety of FORE8394, an inhibitor of BRAF Class 1 and Class 2 alterations, in participan … Recruiting
  2024-513578-23-00 4 2023-03-21 Tumors harboring BRAF alterations
• Maintenance Pembrolizumab at Usual or Low doSE in non-squamous lung cancer: a non-inferiority study Recruiting
  2023-503481-23-00 5 2023-03-20 Maintenance treatment in metastatic non-squamous lung cancer
• Clinical trial of androgen deprivation therapy combined with salvage radiotherapy when treating prostate cancer that has suffered recurrence … Recruiting
  2024-517666-41-00 5 2023-03-13 Prostate Cancer
• A study with eptinezumab in children and adolescents (6 to 17 years) with chronic or episodic migraine (REJOIN) Recruiting
  2022-502917-27-00 5 2023-03-07 Migraine
• Long-Term Follow-up: Phase I/II clinical study to evaluate the safety and efficacy of the infusion of RP-L102 Recruiting
  2022-501082-52-00 9 2023-03-01 Fanconi anemia subtype A (FA-A)
• Phase I/Ib clinical trial of PM54 in Advance Solid Tumors patients Recruiting
  2023-508644-22-00 7 2023-02-28 Advance Solid Tumors
• Combined treatment of intraperitoneal chemotherapy after optimal interval surgery in advanced ovarian cancer. BICOV-1 (Bidirectional Chemoth … Recruiting
  2022-502691-23-00 6 2023-02-27 Ovarian cancer
• Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN). Recruiting
  2023-507233-19-00 10 2023-02-16 Treatment of IgAN
• Study of efficacy and safety of LNP023 in participants with active lupus nephritis Class III-IV, +/- V Recruiting
  2023-509332-26-00 4 2023-02-16 Lupus Nephritis Class III-IV, +/- V
• A Study to Evaluate the Efficacy and Safety of BIIB059 in Participants With Active Subacute Cutaneous Lupus Erythematosus and/or Chronic Cut … Recruiting
  2023-505634-94-00 10 2023-02-02 Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythe
• A Phase 2, Open-Label, Parallel Cohort Study of Subcutaneous Amivantamab in Multiple Regimens in Patients with Advanced or Metastatic Solid … Recruiting
  2023-505065-91-00 4 2023-01-30 Advanced or Metastatic Solid Tumors including EGFR-mutated Non-Small C
• Phase 1b/2a Study to Evaluate CC-92480 (BMS-986348) in Combination with Other Treatments in Relapsed or Refractory Multiple Myeloma Recruiting
  2023-509384-25-00 9 2022-12-30 Relapsed or Refractory Multiple Myeloma (RRMM)
• Phase I Study of PM534 Administered to Patients with Advanced Solid Tumors Recruiting
  2024-513056-15-00 7 2022-12-01 Advanced Solid Tumors
• Clinical study to test the safety, tolerance and preliminary efficacy of oral ITF3756 administered alone or in combination with an anti-prot … Recruiting
  2022-501089-22-00 1 2022-11-29 Advanced solid tumors
• A First-in-Human Dose Escalation Study of JNJ-79635322, in Participants with Relapsed or Refractory Multiple Myeloma or Previously Treated A … Recruiting
  2023-503679-12-00 1 2022-11-21 Relapsed or Refractory Multiple Myeloma
• A Phase 3, multicenter, randomized, evaluator-blinded clinical trial to assess the safety and efficacy of Clobetasol propionate ophthalmic n … Recruiting
  2024-513489-20-00 5 2022-11-21 Inflammation and pain associated with ocular surgery

Showing 1,489–1,512 of 3,550 trials